Johnson & Johnson, a Fair360 Hall of Fame company, recently released its 2023 Diversity, Equity & Inclusion Impact Review. The report underscores the company’s enduring commitment to creating an inclusive and equitable environment. Johnson & Johnson roots its inclusion efforts in its Credo. This value statement emphasizes the company’s responsibility to its patients, employees and communities. The review showcases how diversity, equity and inclusion (DEI) drive innovation and business success at Johnson & Johnson.
The company has made significant strides toward diverse representation within its workforce. By the end of 2023, 49% of management positions globally were held by women. This puts the company on track to meet its 2025 goal of 50%. Additionally, 6.5% of management positions in the U.S. were held by Black and African American employees, nearing the 2025 target of 6.8%.
A notable project driving the connection between the company’s DEI and business strategies is the Our Race to Health Equity initiative. This initiative, backed by an $80 million investment, aims to close the racial health gap by providing vital health services and information. It also includes training investments for over 600,000 healthcare professionals to deliver culturally conscious care. The program has reached 4.5 million people of color in the U.S. since 2020.
Leadership Accountability for Diversity, Equity and Inclusion
Johnson & Johnson holds itself accountable to its DEI strategy through the use of the DEI Maturity Model. This pioneering tool provides a detailed quantitative analysis across more than 140 criteria to monitor successful outcomes. Piloted in five countries, this model tailors DEI strategies to specific regional needs, enhancing the company’s global DEI impact.
The report demonstrates Johnson & Johnson’s proactive approach to DEI. Through leadership accountability and actionable strategic goals, the company is able to leverage workplace inclusion to drive innovation and meet the needs of its global workforce and community of patients.
Access the full 2023 Diversity, Equity & Inclusion Impact Review
